RenovoRx stock regains Nasdaq $1 bid compliance

RenovoRx, Inc. (RNXT) reports that its common stock has regained compliance with Nasdaq’s Minimum Bid Price Requirement under Listing Rule 5550(a)(2).

Rhea-AI Filing Summary

RenovoRx, Inc. (RNXT) reports that its common stock has regained compliance with Nasdaq’s Minimum Bid Price Requirement under Listing Rule 5550(a)(2). The company previously received notice of non-compliance on December 31, 2025, after its closing bid price remained below $1.00 per share for 30 consecutive business days.

Nasdaq informed RenovoRx on August 20, 2026 that, for the ten consecutive business days from August 6, 2026 through August 19, 2026, the closing bid price of its common stock was $1.00 per share or greater. As a result, RenovoRx is now back in compliance with the Nasdaq minimum bid price standard and Nasdaq considers the matter closed.

Positive

• RenovoRx has regained compliance with Nasdaq’s Minimum Bid Price Requirement, removing the immediate delisting risk related to its stock price.
• The stock met the minimum bid price of $1.00 per share or higher for 10 consecutive business days, confirming sustained compliance rather than a single-day spike.

Negative

• None.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Minimum bid price threshold: $1.00 per share Compliance measurement period: 10 consecutive business days Non-compliance notice date: December 31, 2025 +1 more

4 metrics

Minimum bid price threshold $1.00 per share Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement

Compliance measurement period 10 consecutive business days From August 6, 2026 through August 19, 2026 with closing bid at or above $1.00

Non-compliance notice date December 31, 2025 Date Nasdaq notified RenovoRx of failure to meet the Minimum Bid Price Requirement

Compliance confirmation date August 20, 2026 Date Nasdaq informed RenovoRx that it had regained compliance and closed the matter

Key Terms

Minimum Bid Price Requirement, Nasdaq Listing Rule 5550(a)(2), closing bid price

3 terms

Minimum Bid Price Requirement market

"RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement"

A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.

Nasdaq Listing Rule 5550(a)(2) regulatory

"not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”)"

closing bid price market

"the closing bid price of the Common Stock had been $1.00 per share or greater"

The closing bid price is the last price that a buyer was willing to pay for a security at the end of the trading day. It reflects the final visible demand for the stock — like the last offer someone makes for a used car before a yard closes — and helps investors gauge market interest, set valuations, and mark portfolios to market for that day.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RenovoRx (RNXT) announce regarding its Nasdaq listing status?

RenovoRx announced that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Requirement. Nasdaq notified the company that the matter is now considered closed after the stock traded at or above $1.00 per share for 10 consecutive business days.

Why was RenovoRx (RNXT) previously non-compliant with Nasdaq rules?

On December 31, 2025, RenovoRx received notice from Nasdaq that it was not in compliance with Listing Rule 5550(a)(2) because its closing bid price had been below $1.00 per share for the preceding 30 consecutive business days.

How did RenovoRx (RNXT) regain compliance with the Nasdaq minimum bid price rule?

Nasdaq confirmed that from August 6, 2026 through August 19, 2026, RenovoRx’s closing bid price was $1.00 per share or greater for 10 consecutive business days, satisfying the Minimum Bid Price Requirement and restoring compliance.

Does Nasdaq still have an open compliance issue with RenovoRx (RNXT)?

No. Nasdaq informed RenovoRx on August 20, 2026 that the company has regained compliance with the Minimum Bid Price Requirement and that Nasdaq now considers the matter closed.

What Nasdaq rule applies to RenovoRx’s minimum bid price requirement?

RenovoRx’s stock is subject to Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The company regained compliance after maintaining a closing bid at or above this level for 10 consecutive business days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/20/2026 - 04:05 PM EDT Learn about SEC filing dates

false 0001574094 0001574094 2026-08-20 2026-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 20, 2026

RENOVORX, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-40738		27-1448452
(State or other jurisdiction		(Commission		(IRS Employer
of incorporation)		File Number)		Identification No.)

2570 W El Camino Real, Suite 640 Mountain View, CA		94040
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (650) 284-4433

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		RNXT		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

As previously disclosed, on December 31, 2025, RenovoRx, Inc. (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), had been below $1.00 per share for the preceding 30 consecutive business days.

On August 20, 2026, the Company received written confirmation from Nasdaq notifying the Company that for the ten consecutive business days from August 6, 2026 through August 19, 2026, the closing bid price of the Common Stock had been $1.00 per share or greater. Accordingly, the Company has regained compliance with the Minimum Bid Price Requirement and Nasdaq considers the matter closed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RENOVORX, INC.
Date: August 20, 2026
	By:	/s/ Shaun R. Bagai
	Name:	Shaun R. Bagai
	Title:	Chief Executive Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB